Resorufin Phosphocholine

Glycerophosphocholine phosphodiesterase release phosphocholine from resorufin phosphocholine to give the highly fluorescent resorufin that can be readily monitored by either fluorescence or absorption. This fluorogenic phosphodiesterase substrate can be conveniently used for screening the inhibitors of glycerophosphocholine phosphodiesterase. It can also be used for monitoring the activities of phospholipase D in combination with a phosphatase. Phospholipase D hydrolyzes resorufin phosphocholine to resorufin phosphate, which in the presence of an acid phosphatase generates resorufin. Thus, resorufin phosphocholine can also be used for monitoring phospholipase D in sources that do not also contain high levels of phospholipase C.

Protocol

SDS

COA

Catalog	Size	Price	Quantity
11640	1 mg	Price

Calculators

Common stock solution preparation

Table 1. Volume of Water needed to reconstitute specific mass of Resorufin Phosphocholine to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

	0.1 mg	0.5 mg	1 mg	5 mg	10 mg
1 mM	264.326 µL	1.322 mL	2.643 mL	13.216 mL	26.433 mL
5 mM	52.865 µL	264.326 µL	528.653 µL	2.643 mL	5.287 mL
10 mM	26.433 µL	132.163 µL	264.326 µL	1.322 mL	2.643 mL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)		Molecular weight		Volume (Calculate)		Concentration (Calculate)		Moles
mg	÷	378.32 g/mol	=	mL	x	mM	=	mmol

References

View all 81 references: Citation Explorer

Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay

Authors:

March, undefined and C, Lea WA, Jadhav A, Dexheimer TS, Austin CP, Inglese J, Pommier Y, Simeonov A.

Journal:

Mol Cancer Ther (2009): 240

The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction

Authors:

Kaiho Y, Nishiguchi J, Kwon DD, Chancellor MB, Arai Y, Snyder PB, Yoshimura N.

Journal:

BJU Int (2008): 615

Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke

Authors:

Teramoto S, Yamamoto H, Yamaguchi Y, Ishii M, Hibi S, Kume H, Ouchi Y.

Journal:

J Am Geriatr Soc (2008): 1153

Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase

Authors:

Dell'Agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E.

Journal:

Br J Nutr (2008): 945

Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE)

Authors:

Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX.

Journal:

Phytomedicine (2008): 783

Physical properties

Molecular weight	378.32
Solvent	Water

Spectral properties

Absorbance (nm)	570
Extinction coefficient (cm ^-1 M ^-1)	65000 ¹
Excitation (nm)	571
Emission (nm)	584
Quantum yield	0.75 ¹

Storage, safety and handling

H-phrase	H303, H313, H333
Hazard symbol	XN
Intended use	Research Use Only (RUO)
R-phrase	R20, R21, R22
Storage	Freeze (< -15 °C); Minimize light exposure
UNSPSC	12171501

Telephone
Fax
Email	sales@aatbio.com
International	See distributors
Bulk request	Inquire
Custom size	Inquire
Technical Support	Contact us
Request quotation	Request
Purchase order	Send to sales@aatbio.com
Shipping	Standard overnight for United States, inquire for international

Page updated on October 12, 2025